Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety Study to Investigate the Improved FiberSense Continuous Glucose Monitoring System in Diabetic Patients

NCT05133973 is registered in ClinicalTrials.gov with EyeSense GmbH as lead sponsor.

NCT NCT05133973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05133973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety Study to Investigate the Improved FiberSense Continuous Glucose Monitoring System in Diabetic Patients
Lead sponsor
EyeSense GmbH
Phase
Not applicable
Overall status
Completed
Start date
October 10, 2022
Completion date
May 17, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes